COVID19

Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

 March 28, 2022 | News

iMeddy provides free video medical consultation to COVID-19 patients

The service is being carried out in two phases. The first phase, which is now complete, targeted low-income families, while the upcoming second phase will ...

 March 25, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia

The MOH Malaysia recommends using Convidecia™ as a heterologous booster for individuals aged 18 and above who have been administered two doses of ina...

 March 23, 2022 | News

Novavax and SII Announce First EUA of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized&n...

 March 23, 2022 | News

Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules

These experimental results show that Lianhua Qingwen Capsules have significant inhibiting effect on the cytopathic effect induced by Omicron variant so as ...

 March 22, 2022 | News

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries

Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...

 March 21, 2022 | News

Novavax Announces Launch of Global Vaccine Education Programs

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 March 11, 2022 | News

Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era

Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today, announced the CE-IVD marking of its Allplex™ SARS-CoV...

 February 25, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...

 February 21, 2022 | News

TGA Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)

"The TGA authorization for the use of our COVID-19 vaccine in children 6-11 years old in Australia is an important milestone for Moderna as it is the first...

 February 18, 2022 | News

Singapore brand Buzud unveils High Flow Nasal Cannula developed to speed up COVID-19 patients’ recovery

The BUZUD HFNC is approved by Singapore’s Health Sciences Authority (HSA) and provides adequately heated and humidified respiratory gases to spontane...

 February 16, 2022 | News

Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 February 15, 2022 | News

Pluslife Biotech Launches First Handheld Covid-19 Nucleic Acid Test

Hong Kong has been severely hit by the latest wave of COVID-19 infections in recent weeks. In response to challenges including the lack of manpower fo...

 February 15, 2022 | News

Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil

- Seegene to sign a contract with the Brazilian government to supply 4 million COVID-19 tests and associated consumables - 'Allplex™ SARS-CoV-2/FluA...

 February 14, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close